AAOpt 2022: Knowing how to treat refractive error in pediatric patients, an evidence-based approach

Video

Graham Erickson, OD, FAAO, FCOVD, shares highlights from his 2022 American Academy of Optometry presentation, "Evidence-based refractive prescribing for pediatric patients."

Graham Erickson, OD, FAAO, FCOVD, professor at Pacific University in Oregon, speaks with Optometry Times®' Kassi Jackson on highlights from his discussion titled, "Evidence-based refractive prescribing for pediatric patients," which he presented during the 2022 American Academy of Optometry (AAOpt) annual meeting in San Diego.

Editor's note: This transcript has been edited for clarity.

Jackson:

Hi, everyone. I'm Kassi Jackson with Optometry Times, and I'm joined today by Dr. Graham Erickson, professor at Pacific University in Oregon. He's here to share highlights from his discussion titled, "Evidence-based refractive prescribing for pediatric patients," which he's presenting during the 2022 American Academy of Optometry meeting this year in San Diego. Thank you for being here. Dr. Erickson, tell us about your talk.

Erickson:

Oh, thank you for having me. I think that in the area of pediatric eye care, as optometrists, we have 2 significant challenges. And the first is getting the information we need to make decisions about these young patients who can be challenging sometimes to examine. But the second part of it is, what do we do with that information? How do we make the best decisions for our patients?

And one of the biggest areas as optometrist that we have to contend with is refractive error, because it is common to find refractive errors in our young patients. But we also know that there are growth factors that will help sort of self-correct those refractive errors in many cases. So prescribing may not be necessary. And that's our challenge. We are stuck between should I correct this refractive error? Or should I sort of let it ride and let nature take its course, and there's no need to provide refractive correction? So that's really the focus...

I think we've learned a lot from research in the past 20 to 30 years, that helped guide those kinds of decisions about the timing, the amount of refractive error, the amount of correction to provide to these patients when it is required.

And that's where I will spend the hours, is going through each of those refractive errors one at a time, [and] make sure we understand all the parameters and the decision mechanisms to make hopefully the best decisions for our patients.

Jackson:

Yeah, and you kind of just alluded to it, but why is this so important for optometrists to address?

Erickson:

Well, I think that, you know, the main challenge with vision care is sometimes identifying problems early enough to make a significant impact and avoid some of the long term complications if things go undetected and uncorrected for too long. And so, you know, the challenge for optometry is if we do detect a problem, when should we intervene? And what is the best intervention? So I think that's why it's important to optometry...

Refraction is sort of our home. This is this is our expertise. And so we're the ones making those decisions.

Jackson:

Absolutely. And then what do those decisions mean for patient care?

Erickson:

Well, patient care, it means the difference between my little princess wearing their glasses, or you know, maybe that's not the best option. And sometimes it's even, you know, would a contact lens prescription be a better route for this patient? And so it's really helping the families who really have no idea what's going on or what the best decisions are to understand better and help make the best decisions for their child.

Jackson:

Dr. Erickson, thank you so much for your time today.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
© 2025 MJH Life Sciences

All rights reserved.